Funder: European Commission
Due Dates: April 13, 2027
Funding Amounts: €8–10 million per project; total topic budget €44.2 million; up to 5 grants expected
Summary: Supports the development and clinical advancement of innovative antibacterial and antifungal therapies to combat antimicrobial-resistant pathogens.
Key Information: Single-stage call under Horizon Europe; strong focus on regulatory engagement and clinical studies.